(Q33360969)

26 July 2017

title

Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study (English)

1 reference

26 July 2017

0 references

1 reference

tuberculous meningitis

1 reference

based on heuristic

inferred from title

author

Willem Albert Hanekom

5

object named as

Willem A Hanekom

1 reference

26 July 2017

7

Gilla Kaplan

1 reference

26 July 2017

Johan F Schoeman

1

1 reference

26 July 2017

Priscilla Springer

2

1 reference

26 July 2017

Anita Janse van Rensburg

3

1 reference

26 July 2017

Sonja Swanevelder

4

1 reference

26 July 2017

Patrick A J Haslett

6

1 reference

26 July 2017

publication date

1 April 2004

1 reference

Journal of Child Neurology

26 July 2017

published in

1 reference

26 July 2017

volume

19

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

250-257

1 reference

Pediatric meningitis in the Western Cape Province of South Africa

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

Long-term thalidomide use in refractory cutaneous lesions of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

Factors of prognostic significance in Chinese children with tuberculous meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

Behçet's disease in UK children: clinical features and treatment including thalidomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

Efficacy of long-term treatment with thalidomide in children and young adults with Crohn disease: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900402

10.1177/088307380401900402

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference